Robotic and Thoracoscopic Surgery for Lung Cancer
A special issue of Cancers (ISSN 2072-6694). This special issue belongs to the section "Methods and Technologies Development".
Deadline for manuscript submissions: 28 February 2027 | Viewed by 620
Editor
Special Issue Information
Dear Colleagues,
Minimally invasive lung resection has become the standard of care for early-stage lung cancer over the past two decades, and studies have demonstrated its superiority over lung resection via thoracotomy with regard to patient recovery, perioperative complications, and even oncologic outcomes and survival. Current research focuses on comparisons between robotic and non-robotic thoracoscopic lung resections, each of which offers advantages and disadvantages over the other. Recently, attention has focused on controversial topics such as the role of lobectomy vs. sublobar resection for lung cancer, radiomic and pathologic indicators of increased recurrence risk (“high risk” stage I lung cancer), the recommended extent of lymph node dissection, and the role of neoadjuvant chemoimmunotherapy in the care of lung cancer patients. This Special Issue will examine the current data on some of these controversial issues to help guide the practice of modern-day general thoracic surgeons.
Prof. Dr. Benjamin Wei
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-anonymized peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cancers is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- robotic
- thoracoscopic
- lobectomy
- segmentectomy
- wedge resection
- lymph node dissection
- neoadjuvant therapy
- immunotherapy
- spread through air spaces
- radiomics
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
